Combination of bispecific antibodies enable targeted TNFRSF agonism and effective antitumor activity
Lucie Diby,1,2 Pauline Malinge,1 Valery Moine,1 Lise Nouveau,1 Laurence Chatel,1 Krzysztof Masternak,1
Limin Shang,1 Walter Ferlin,1 Nicolas Fischer,1 Mark S. Cragg,3 Mikael Pittet,2 Vanessa Buatois,1 and Eric Hatterer1
Light Chain Bioscience is thrilled to share that our latest research has been published in Molecular Therapy !
Read: Full article
